28 results
6-K
EX-99.1
INCR
Intercure Ltd
21 May 24
Current report (foreign)
4:30pm
District Court issued a judgment dismissing the personal claims of each plaintiff and the said class action lawsuit against the defendants, ordering
6-K
EX-99.1
INCR
Intercure Ltd
31 Oct 23
Current report (foreign)
4:51pm
the lawsuit that filed against the Company by minority shareholders of its subsidiary, Cannolam Ltd. (“Cannolam”), and the parties agreed on a binding
6-K
EX-99.1
INCR
Intercure Ltd
31 Aug 23
InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY
5:28pm
primarily on our ultra-medical and legacy products.
On June 15, 2023, Tel Aviv-Jaffa District Court dismissed the lawsuit against Intercure … shareholders of Cannolam. Previously, on April 24, 2023, a lawsuit was filed against Intercure in Tel Aviv-Jaffa District Court in Israel by minority
6-K
EX-99.1
INCR
Intercure Ltd
12 Jun 23
InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger
8:00am
Exhibit 99.1
InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger
NEW YORK … reported that it had filed a lawsuit against Better to recover funds loaned to Better in the course of their dealings in connection with the Agreement
6-K
EX-99.3
71vzpphstsxc0 rjthbb
16 May 23
InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY
6:06am
6-K
EX-99.1
0zrb2pt17qf
16 May 23
InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY
6:06am
6-K
EX-99.2
pgqlom n910
16 May 23
InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY
6:06am
6-K
EX-99.1
fq9a aeoiakb
26 Apr 23
InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary
8:00am
6-K
EX-99.4
7p9apm4
3 Apr 23
InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results
8:00am
6-K
EX-99.2
ulpgwtre6 nxd
3 Apr 23
InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results
8:00am
6-K
EX-99.1
4zy9tt2z2nzhn4z
3 Apr 23
InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results
8:00am
6-K
EX-99.3
gz2bw8rc2qgtqc1b7ruj
3 Apr 23
InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results
8:00am
6-K
EX-99.1
rrkpvdng1dikq 87f
5 Dec 22
InterCure Announces the Withdrawal of a Class Action Lawsuit against it
4:42pm
20-F
apwgxhb
28 Apr 22
Annual report (foreign)
12:02pm
6-K
EX-99.1
8td3 dj0m
7 Apr 22
Current report (foreign)
4:31pm
424B3
mjeaix2nkuzlzru
4 Oct 21
Prospectus supplement
5:16pm
F-1/A
l918hpa
23 Sep 21
Registration statement (foreign) (amended)
2:24pm
F-1/A
oqjoiazui
9 Sep 21
Registration statement (foreign) (amended)
3:18pm